| abstract |
The present invention relates to the use of a Chinese medicine composition in the manufacture of a medicament for the secondary prevention of myocardial infarction. The herbal composition is prepared from a formulation consisting of a crude drug by the following weight percentage: Radix Astragli 22.2% to 66.8%, Radix Salviae Miltiorrhizae 11.6% to 33.4%, Radix ginseng (Radix) Notoginseng) 2.5% to 13.5%, and Lignum Dalbergiae Odoriferae 14.5% to 44.3%. |